Lack of a role for the D3 receptor in clozapine induction of c-fos demonstrated in D3 dopamine receptor-deficient mice

Neuroscience

Volumn 90, Issue 3, 1999, Pages 1021-1029

  Carta, A R ^a   Gerfen, C R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

c fos; Clozapine; D3 receptor; Dopamine; Striatum

Indexed keywords

CLOZAPINE; DIGOXIGENIN; DOPAMINE 3 RECEPTOR; ENKEPHALIN; MESSENGER RNA; PROTEIN C FOS; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, MOUSE; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEPTUM PELLUCIDUM; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL; ONCOGENE; PHENOTYPE; PHYSIOLOGY;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CORPUS STRIATUM; GENE EXPRESSION REGULATION; GENES, FOS; MICE; NEURONS; NUCLEUS ACCUMBENS; PHENOTYPE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER;

EID: 0032589222     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00498-9     Document Type: Article

References (29)

1. Accili D., Fishburn C. S., Drago J., Steiner H., Lachowicz J. E., Park B. H., Gauda E. B., Lee E. J., Cool M. H., Sibley D. R., Gerfen C. R., Westphal H., Fuchs S. A targeted mutation of the mouse dopamine D3 receptor gene acts in a dominant fashion and is associated with hyperactivity in mice. Proc. natn. Acad. Sci. U.S.A. 93:1996;1945-1949.
2. Ahlenius S., Salmi P. Behavioral and biochemical effect of the dopamine D3 receptor-selective ligand, 7-OHDPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmac. 260:1994;177-181.
3. Cooper D. C., Koeltzow T. E., Xu M., Tonegawa S., White F. J., Wolf M. E. Regulation of dopamine release and synthesis in dopamine D3R receptor knockout mice. Soc. Neurosci. Abstr. 22:1996;13A.
4. Deutch A., Lee M. C., Iadarola M. J. Regionally specific effects of atypical antipsychotic drugs on striatal fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Molec. cell. Neurosci. 3:1992;332-341.
5. Gerfen C. R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. A. Rev. Neurosci. 15:1992;285-320.
6. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J., Sibley D. R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
7. Gerfen C. R., Keefe A. K., Gauda E. B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1 and D2 dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1 containing neurons. J. Neurosci. 15:1995;8167-8176.
8. Guo N., Klitenick M. A., Tham C. S., Fibiger H. C. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience. 65:1995;747-756.
9. Invernizzi R., Pozzi L., Samanin R. Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats. Brain Res. 670:1995;165-168.
10. Landwehrmeyer B., Mengod G., Palacios J. M. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5:1993;145-153.
11. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. comp. Neurol. 355:1995;418-426.
12. Le Moine C., Bloch B. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience. 73:1996;131-143.
13. Le Moine C., Normand E., Block C. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88:1991;4205-4209.
14. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. natn. Acad. Sci. U.S.A. 87:1990;230-234.
15. 3H)hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. natn. Acad. Sci. U.S.A. 89:1992;8155-8159.
16. MacGibbon G. A., Lawlor P. A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in the rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Molec. Brain Res. 23:1994;21-32.
17. Meltzer H. Y. Role of serotonin in the action of atypical antipsychotic drugs. Clin. Neurosci. 3:1995;64-75.
18. i values. J. Pharmac. exp. Ther. 251:1989;238-246.
19. Moghaddam B., Bunney B. S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54:1990;1755-1760.
20. Murray A. M. The interaction of clozapine with D1 versus dopamine D2 receptor mediated function: behavioral indices. Eur. J. Pharmac. 186:1990;79-86.
21. Nordstrom A. L., Farde L., Nyberg S., Karlsson P., Halldin C., Sedvall G. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am. J. Psychiat. 15:1995;1444-1449.
22. Robertson G. S., Fibiger H. C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328.
23. Salmi P., Ahlenius Further evidence for clozapine as a dopamine D1 receptor agonist. Eur. J. Pharmac. 307:1996;27-31.
24. Sautel F., Griffon N., Levesque D., Pilon C., Schwartz J. C., Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. NeuroReport. 6:1995;329-332.
25. Sethy V. H., Ellerbrock B., Fici G. J., Wu H. D2 and D1 dopaminergic activity of 7-OHDPAT. Brain Res. 733:1996;41-45.
26. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
27. Van Beveren C., van Straaten F., Curran T., Muller R., Verma I. M. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell. 32:1983;1241-1255.
28. Waters N., Lofberg L., Haadsma-Svensson S., Svensson K., Sonesson C., Carlsson A. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behavior. J. neural Transm. 98:1994;39-55.
29. Yoshikawa K., Williams C., Sabol S. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the nervous system. J. biol. Chem. 259:1984;14,301-14,308.